» Articles » PMID: 37798852

Comparative Olfactory Profiles in Parkinson's Disease and Drug-Induced Parkinsonism

Overview
Journal J Mov Disord
Date 2023 Oct 6
PMID 37798852
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Drug-induced parkinsonism (DIP) is a frequently encountered diagnostic possibility when considering Parkinson's disease (PD). While olfactory dysfunction is a common clinical feature in PD, the comparison of olfactory function between the two conditions remains insufficient. This study aimed to compare olfactory function, including threshold, discrimination, and identification (TDI) profiles, between PD and DIP.

Methods: Consecutive patients with drug-naïve PD (n = 78) or DIP (n = 31) confirmed through dopamine transporter imaging were enrolled in this study. The YSK olfactory function (YOF) test, composed of TDI domains culturally familiar odorants to Koreans, was administered to all patients.

Results: In the study population, patients with DIP were significantly older than patients with PD. Over 70% of patients in each group had hyposmia or anosmia, and there was no significant difference in the occurrence of olfactory dysfunction between the two groups. In addition, there were no differences in the total YOF score and threshold score between the two groups. Meanwhile, the PD group had a significantly lower discrimination and identification score than the DIP group after adjusting for age, sex, the existence of diabetes, disease duration, and cognitive function.

Conclusion: This study demonstrated that detailed olfactory profiles are different in PD and DIP, even though olfactory dysfunction can be observed in both conditions.

Citing Articles

Olfactory dysfunction as potential biomarker in neurodegenerative diseases: a narrative review.

De Cleene N, Schwarzova K, Labrecque S, Cerejo C, Djamshidian A, Seppi K Front Neurosci. 2025; 18():1505029.

PMID: 39840019 PMC: 11747286. DOI: 10.3389/fnins.2024.1505029.

References
1.
Shin H, Chung S . Drug-induced parkinsonism. J Clin Neurol. 2012; 8(1):15-21. PMC: 3325428. DOI: 10.3988/jcn.2012.8.1.15. View

2.
Bhatia-Dey N, Heinbockel T . The Olfactory System as Marker of Neurodegeneration in Aging, Neurological and Neuropsychiatric Disorders. Int J Environ Res Public Health. 2021; 18(13). PMC: 8297221. DOI: 10.3390/ijerph18136976. View

3.
Gelb D, Oliver E, Gilman S . Diagnostic criteria for Parkinson disease. Arch Neurol. 1999; 56(1):33-9. DOI: 10.1001/archneur.56.1.33. View

4.
Postuma R, Berg D, Stern M, Poewe W, Olanow C, Oertel W . MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015; 30(12):1591-601. DOI: 10.1002/mds.26424. View

5.
Doty R . Olfactory dysfunction in Parkinson disease. Nat Rev Neurol. 2012; 8(6):329-39. DOI: 10.1038/nrneurol.2012.80. View